Upregulation in myeloid and bowel tumors was found in several studies [35,36]; the overexpression of SLC34A2 was found in endometrioid and papillary serous ovarian carcinomas [14,15,16,37,38], and it was shown that in uterine (endometrial) cancer, SLC34A2 expression appeared relatively increased [14,16]. The gene discussed is SLC34A2; the disease is endometrial cancer.